Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXC | Common Stock | Options Exercise | $637K | +16K | +76.85% | $39.81 | 36.8K | Nov 24, 2021 | Direct | F1 |
transaction | EXC | Common Stock | Sale | -$870K | -16K | -43.45% | $54.39 | 20.8K | Nov 24, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXC | NQ Stock Option (right to buy) 03/12/2012 | Options Exercise | -16K | -100% | 0 | Nov 24, 2021 | Common Stock | 16K | $39.81 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Exercise and sale made pursuant to a Rule 10b5-1 trading plan entered into by Mr. Dominguez on November 10, 2021. |
F2 | Shares sold in individual lots with prices ranging from $54.01 to $54.64 inclusive. Mr. Dominguez undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission full details of the number of shares sold at each individual price within the range provided above. |
F3 | Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. |